跳至主要内容
临床试验/IRCT201012031556N19
IRCT201012031556N19已完成2 期

A double - blind placebo controlled trial of Ginkgo Biloba added to risperidone in patint with autistic disorder

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
3 years 至 12 years(—)
性别
All

入选标准

  • Inclusion Criteria: DSM IV clinical diagnosis of autism, children and adolescents between the ages of 3 and 12 years (inclusive),

排除标准

  • Presence of any active medical problem, any diagnosis in Axis I and II except for mental retatdation, history of allergy to Ginkgo Biloba, receiving any psychotropic medications during past two weeks prior to the trial

研究者

相似试验